Posts

Posted on

Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call

PR Newswire

FRANKLIN, Tenn., Jan. 20, 2021 /PRNewswire/ — Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that on Tuesday evening, February 16, 2021, after the market closes, it will report results for the fourth quarter of 2020. 

On February 17, 2021, at 9:00 a.m. Central Time, Community Healthcare Trust will hold a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.  Simultaneously, a webcast of the conference call will be available to interested parties via an Internet link at www.chct.reit under the Investor Relations section.  A webcast replay will be available following the call at the same Internet site address.

Conference Call Details
Domestic Dial-In Number: 1-888-347-1332
International Dial-In Number: 1-412-902-4278
Canada Toll Free: 1-855-669-9657

Replay Conference Call Details
Domestic Dial-In Number: 1-877-344-7529
International Dial-In Number: 1-412-317-0088
Canada Toll Free: 1-855-669-9658
Conference ID:   10151368

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. The Company had investments of approximately $667.3 million in 131 real estate properties as of September 30, 2020, located in 33 states, totaling approximately 2.8 million square feet.


Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes”, “expects”, “may”, “should”, “seeks”, “approximately”, “intends”, “plans”, “estimates”, “anticipates” or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, the Company’s ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof.  The Company intends these forward-looking statements to speak only as of the time of this release and the Company undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.

CONTACT:  David H. Dupuy, 615-771-3052

Cision View original content:http://www.prnewswire.com/news-releases/community-healthcare-trust-announces-fourth-quarter-earnings-release-date-and-conference-call-301212099.html

SOURCE Community Healthcare Trust, Inc.

Posted on

Mytheresa Announces Pricing Of Initial Public Offering

PR Newswire

MUNICH, Jan. 20, 2021 /PRNewswire/ — MYT Netherlands Parent B.V. (“Mytheresa” or the “Company”), the parent company of the Mytheresa Group GmbH, today announced the pricing of its initial public offering of 15,647,059 of American Depositary Shares (“ADSs”) at a price of $26.00 per ADS. The Company is selling 13,647,059 ADSs and its sole shareholder is selling 2,000,000 ADSs in the offering. Each ADS represents one ordinary share of the Company. The Company and the selling shareholder have granted the underwriters a 30-day option to purchase up to an additional 2,347,058 ADSs in aggregate at the initial public offering price, less underwriting discounts and commissions.

The shares are expected to begin trading on the New York Stock Exchange on January 21, 2021, under the ticker symbol “MYTE” and the offering is expected to close on January 25, 2021, subject to customary closing conditions.

Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC are acting as lead joint bookrunning managers and representatives of the underwriters for the proposed offering. Credit Suisse Securities (USA) LLC and UBS Securities LLC are acting as joint bookrunning managers for the proposed offering. Jefferies LLC and Cowen and Company, LLC are acting as bookrunning managers for the proposed offering.

A registration statement relating to the sale of these securities was filed with, and declared effective by, the Securities and Exchange Commission (“SEC”) on January 20, 2021. The proposed offering is only being made by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained, when available, from: Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, New York 10014, Attn: Prospectus Department or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 Telephone: 866-803-9204 Email: [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Mytheresa

Mytheresa is one of the leading global luxury fashion e-commerce retailers. Mytheresa was launched in 2006 and offers ready-to-wear, shoes, bags and accessories for women, men and kids. The highly curated offer focuses on true luxury with designer brands such as Bottega Veneta, Burberry, Dolce & Gabbana, Fendi, Gucci, LOEWE, Loro Piana, Moncler, Prada, Saint Laurent, Valentino and many more. Mytheresa’s unique digital experience is based on a sharp focus on high-end luxury shoppers, exclusive product and content offerings, leading technology and analytical platforms as well as high quality service operations.

Forward-Looking Statements
This press release includes “forward looking information,” including with respect to the initial public offering. These statements are made through the use of words or phrases such as “will” or “expect” and similar words and expressions of the future. Forward-looking statements involve known and unknown risks, uncertainties and assumptions, including the risks outlined under “Risk Factors” in the preliminary prospectus and elsewhere in the Company’s filings with the SEC, which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this press release to reflect changes since the date of this press release, except as required by law.


Media Contacts for public relations


Media Contacts for business press

Mytheresa.com GmbH

Edelman USA

Sandra Romano

Ted McHugh / Nicole Briguet

mobile: +49 152 54725178

phone: +1 201 341-0211 / +1 646 750-7235

phone: +49 89 127695-236

email: [email protected] 

email: [email protected]

email: [email protected] 

Edelman Germany, Austria, Switzerland

Ruediger Assion

mobile: +49 162 4909624

phone: +49 221 8282 8111

email: [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/mytheresa-announces-pricing-of-initial-public-offering-301212098.html

SOURCE Mytheresa

Posted on

KORE Mining Shareholders Overwhelmingly Approve Spin-Out of British Columbia Exploration Assets Creating Karus Gold

PR Newswire


High Grade Gold Discovery Provides Catalyst for Exploration Spin Out

VANCOUVER, BC, Jan. 20, 2021 /PRNewswire/ – KORE Mining Ltd. (TSXV: KORE) (OTCQX: KOREF) (“KORE” or the “Company“) is pleased to announce that with respect to its special meeting of shareholders held today (the “Meeting“), all of the resolutions were duly passed, including the special resolution (the “Arrangement Resolution“) to approve the proposed plan of arrangement (the “Arrangement“) pursuant to which KORE will spin-out its British Columbia exploration assets to Karus Gold Corp. (“Karus Gold“).

KORE CEO Scott Trebilcock commented, “With the recent high-grade gold discovery at FG Gold of 14.35 meters of 6.44 g/t gold and drill results across 1.8 kilometers of strike from 14 pending holes, Karus is strongly positioned to attract capital and generate significant value for shareholders. We are excited to see Karus’ assets exposed to the valuation forces for a pure play explorer with high grade drill results in an excellent jurisdiction.”

Pursuant to the Arrangement, the owners of common shares of KORE as of the close of business on the day before (anticipated to be January 22, 2021) the effective date of the Arrangement (anticipated to be January 25, 2021) will receive: (i) one-half of a common share of Karus Gold and (ii) one new common share of KORE, for each common share of KORE held on the day before the effective date of the Arrangement. 

There is no change to a shareholder’s ownership of KORE as a result of the completion of the Arrangement. The majority of shareholders (those who hold their shares through their broker) will receive their Karus shares with no further action. Please contact the Company if you do not get your Karus shares by mid-February. Further information on the Arrangement can be found on the Company’s website www.koremining.com.

Mr. Trebilcock continued, “Karus Gold will now raise seed capital in a rights offering. This is a rare opportunity for shareholders to access seed round financing usually reserved for industry insiders.  Karus then plans to list its shares on the TSX Venture Exchange later in the first half 2021, subject to regulatory approvals.”

The Arrangement Resolution required and received approval by more than: (i) 662/3% of the votes cast by the KORE shareholders present in person or represented by proxy; and (ii) 50% of the votes cast by the KORE shareholders other than those required to be excluded pursuant to Multilateral Instrument 61-101.

Closing of the Arrangement remains subject to final court approval as well as other customary closing conditions. Assuming the timely completion of these conditions, the Company expects the Transaction to close on January 25, 2021.

At the Meeting, KORE shareholders also approved: (i) the stock option plan for Karus Gold; (ii) the omnibus share compensation plan for Karus Gold; and (iii) the advance notice policy for Karus Gold.

This year, in light of the ongoing COVID-19 pandemic, the Meeting was held by way of virtual only format whereby shareholders participated in the Meeting remotely. Voting for each of the resolutions was by ballot.

KORE wishes to clarify its Management Information Circular dated December 18, 2020 in connection with the Meeting (the “Circular“). The Circular referred to a “Distribution Record Date” to be on or about January 22, 2021. To clarify, the reference to this date is not a “record date” but an anticipated date for determining which KORE shareholders will be eligible to receive the consideration disclosed in the paragraph above, pending approval and completion of the Arrangement.

About KORE Mining

KORE is 100% owner of a portfolio of advanced gold exploration and development assets in California and British Columbia. KORE is supported by strategic investor Eric Sprott who owns 26% of KORE’s basic shares. KORE management and Board are aligned with shareholders, owning an additional 38% of the basic shares outstanding. KORE is actively developing its Imperial and Long Valley gold projects and is aggressively exploring across its portfolio of assets.

Further information on the Arrangement and KORE can be found on the Company’s website at www.koremining.com/Karus or by contacting us as [email protected] or 888-455-7620.

On behalf of KORE Mining Ltd

“Scott Trebilcock”
Chief Executive Officer

Karus Gold Spin Out Investor Support

David Jan

1-888-455-7620
[email protected]

KORE Investor Relations

Arlen Hansen, KIN Communications
1-888-684-6730
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Information
This news release contains forward-looking statements relating to the future operations of the Company and Karus Gold and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “plan”, “should”, “anticipate”, “expects”, “intends”, “indicates” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of the Company and Karus Gold are forward-looking statements. Forward-looking statements in this news release include, but are not limited to, the expected timeline and date of completion of the Arrangement, the ability of KORE to receive and obtain court approval, the ability of the parties to satisfy, in a timely manner, the other conditions to closing of the Arrangement, the future listing of Karus Gold and the expected timeline and completion of the anticipated Karus rights offering. There can be no assurance that the Arrangement will be completed or that it will be completed on the terms and conditions contemplated in this news release. The Arrangement could be modified or terminated in accordance with its terms. Such forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business. Management believes that these assumptions are reasonable. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. 

Such factors include, among others: the Arrangement will be completed on the terms currently contemplated, the Arrangement will be completed in accordance with the timing currently expected without any undue delay, all conditions to the completion of the Arrangement will be satisfied or waived in due course and the Arrangement Agreement will not be terminated prior to the completion of the Arrangement, assumptions and expectations related to the trading price of KORE and the future listing of Karus Gold, and other expectations and assumptions concerning the Arrangement. 

In addition to the above summary, additional risks and uncertainties inherent to the Company and its operations are described in the “Risk Factors” section of the Company’s management discussion and analysis for the year ended December 31, 2019, prepared as of April 27, 2020, available under the Company’s issuer profile on www.sedar.com. Other risks and uncertainties include, among other things: the Arrangement may not be completed on the terms, or in accordance with the timing currently contemplated, or at all; the Company and Karus Gold has incurred expenses in connection with the Arrangement and will be required to pay for those expenses regardless of whether or not the Arrangement is completed; the Company and Karus Gold may not be successful in satisfying the conditions to the Arrangement; the possibility of adverse reactions or changes in business relationships resulting from the announcement or completion of the Arrangement; the failure to realize the expected benefits of the Arrangement; and other risks inherent to KORE’s current business and/or factors beyond its control which could have a material adverse effect on KORE or the ability to consummate the Arrangement.

Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results, except as may be required by applicable securities laws. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/kore-mining-shareholders-overwhelmingly-approve-spin-out-of-british-columbia-exploration-assets-creating-karus-gold-301212024.html

SOURCE Kore Mining

Posted on

Kaman Announces New Order for the K-MAX® Helicopter

Kaman Announces New Order for the K-MAX® Helicopter

BLOOMFIELD, Conn.–(BUSINESS WIRE)–
Kaman Air Vehicles, a division of Kaman Corporation (NYSE:KAMN), announced today the receipt of a signed purchase agreement for a K-MAX® medium-to-heavy lift helicopter. Delivery of this aircraft is expected in the first quarter of 2021 and follows the delivery of two aircraft in the fourth quarter of 2020. We continue to see demand and interest in the capabilities of the K-MAX® across multiple markets.

“We are excited for the opportunity to deliver our third K-MAX® aircraft in the last two quarters. Our industry and our operators are benefiting from the cost effective repetitive lift mission capability of the K-MAX®,” stated Roger Wassmuth Senior Director, Business Development. “This demand and our recent type certification in Brazil solidifies the need and value proposition that K-MAX® offers in the global external lift market.”

Development of the improved K-MAX® Unmanned Aerial System continues and we expect the Optionally Piloted Vehicle module to enter ground and flight test in the first half of 2021. Kaman is continuing to develop a commercial Optionally Piloted Aircraft to support its growing customer base, while working with the U.S Marine Corps on upgrading the autonomous capabilities of the unmanned K-MAX®.

“Our team has done a great job assessing the global market, identifying future technologies and working with potential and existing customers to secure additional orders for our K-MAX® helicopter,” said Darlene Smith, President, Kaman Air Vehicles / Precision Products Division. “We are very proud that Kaman continues to provide new K-MAX® aircraft to customers worldwide.”

The K-MAX® is a rugged, low-maintenance aircraft that features a counter-rotating rotor system and is optimized for repetitive external load operations. The aircraft can lift up to 6,000 pounds (2,722 kg) with unmatched performance in hot and high conditions.

About Kaman Corporation

Kaman Corporation, founded in 1945 by aviation pioneer Charles H. Kaman, and headquartered in Bloomfield, Connecticut conducts business in the aerospace & defense, industrial and medical markets. Kaman produces and markets proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft; safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of our SH-2G Super Seasprite maritime helicopters; manufacture and support of our K-MAX® manned and unmanned medium-to-heavy lift helicopters. More information is available at www.kaman.com.

Roger Wassmuth

Senior Director, Business Development

Kaman Air Vehicles

(860) 243-7216 (office)

(860) 595-9112 (mobile)

[email protected]

Media

Kristen Samson

Vice President and Chief Marketing Officer

Kaman Corporation

(860) 243-6330

[email protected]

Investors

James Coogan

VP, Investor Relations and Business Development

Kaman Corporation

(860) 243-6342

[email protected]

KEYWORDS: United States North America Connecticut

INDUSTRY KEYWORDS: Air Transport Aerospace Manufacturing Other Manufacturing Other Transport

MEDIA:

Posted on

Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio

Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio

Special Meeting Scheduled for February 9, 2021

SAN FRANCISCO–(BUSINESS WIRE)–
Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (File No. 333-250036) (as amended, the “Registration Statement”), relating to the previously announced business combination (the “Business Combination”) with Nuvation Bio Inc. (“Nuvation Bio”), has been declared effective by the U.S. Securities and Exchange Commission (“SEC”) and that it has commenced mailing the definitive proxy statement/prospectus relating to the Special Meeting (the “Special Meeting”) of the Company’s stockholders to be held on February 9, 2021 in connection with the Business Combination. The definitive proxy statement/prospectus is being mailed to the Company’s stockholders of record as of the close of business on December 29, 2020. In connection with the Special Meeting, the Company’s stockholders that wish to exercise their redemption rights must do so no later than 5:00 p.m. Eastern Time on February 5, 2021 by following the procedures specified in the definitive proxy statement/prospectus for the Special Meeting.

Forward Looking Statements:

Certain statements included in this press release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding timing of the special meeting for the proposed Business Combination. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the respective management teams of Nuvation Bio and the Company and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Nuvation Bio and the Company. These forward-looking statements are subject to a number of risks and uncertainties, including the risk that the potential product candidates that Nuvation Bio develops may not progress through clinical development or receive required regulatory approvals within expected timelines or at all; the risk that clinical trials may not confirm any safety, potency or other product characteristics described or assumed in this press release; the risk that Nuvation Bio will be unable to successfully market or gain market acceptance of its product candidates; the risk that Nuvation Bio’s product candidates may not be beneficial to patients or successfully commercialized; the risk that Nuvation Bio has overestimated the size of the target patient population, their willingness to try new therapies and the willingness of physicians to prescribe these therapies; the effects of competition on Nuvation Bio’s business; the risk that third parties on which we depend for laboratory, clinical development, manufacturing and other critical services will fail to perform satisfactorily; the risk that Nuvation Bio’s business, operations, clinical development plans and timelines, and supply chain could be adversely affected by the effects of health epidemics, including the ongoing COVID-19 pandemic; the risk that we will be unable to obtain and maintain sufficient intellectual property protection for our investigational products or will infringe the intellectual property protection of others; the potential inability of the parties to successfully or timely consummate the proposed Business Combination, including the risk that the approval of the stockholders of the Company or Nuvation Bio is not obtained; the risk of failure to realize the anticipated benefits of the proposed Business Combination; the amount of redemption requests made by the Company’s stockholders, and those factors discussed in the Company’s final prospectus dated June 30, 2020 under the heading “Risk Factors,” and other documents the Company has filed, or will file, with the SEC, including the Registration Statement. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither the Company nor Nuvation Bio presently know, or that the Company or Nuvation Bio currently believe are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company’s and Nuvation Bio’s expectations, plans, or forecasts of future events and views as of the date of this press release. The Company and Nuvation Bio anticipate that subsequent events and developments will cause the Company’s and Nuvation Bio’s assessments to change. However, while the Company and Nuvation Bio may elect to update these forward-looking statements at some point in the future, the Company and Nuvation Bio specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s and Nuvation Bio’s assessments of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Additional Information and Where to Find It:

This press release relates to a proposed transaction between Nuvation Bio and the Company. This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. In connection with the transaction described herein, the Company has filed and intends to file relevant materials with the SEC, including the Registration Statement which was originally filed with the SEC on November 12, 2020, as amended most recently on January 19, 2021, and declared effective by the SEC on January 20, 2021. The Company has mailed the definitive proxy statement/prospectus and a proxy card to stockholders entitled to vote at the special meeting relating to the transaction. Investors and security holders of the Company are urged to read these materials (including any amendments or supplements thereto) and any other relevant documents in connection with the transaction that the Company has filed or will file with the SEC when they become available because they will contain important information about the Company, Nuvation Bio and the transaction. The preliminary proxy statement/prospectus, the definitive proxy statement/prospectus included in the Registration Statement and other relevant materials in connection with the transaction, and any other documents filed by the Company with the SEC, may be obtained free of charge at the SEC’s website (www.sec.gov). The documents filed by the Company with the SEC also may be obtained free of charge at the Company’s website at panacea.ecor1cap.com or upon written request to 357 Tehama Street, Floor 3, San Francisco, CA 94103.

Participants in Solicitation:

The Company, Nuvation Bio and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the Company’s shareholders in connection with the proposed transaction. Information about the Company’s directors and executive officers and their ownership of the Company’s securities is set forth in the Registration Statement. Additional information regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction may be obtained by reading the definitive proxy statement/prospectus in the Registration Statement regarding the proposed transaction. You may obtain free copies of these documents as described in the preceding paragraph.

Non Solicitation:

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of the Company, the combined company or Nuvation Bio, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.

Source: Panacea Acquisition Corp.

Panacea Contact:

Scott Perlen

[email protected]

415-234-0623

Nuvation Bio Investor Contact:

Argot Partners

Joe Rayne

[email protected]

Nuvation Bio Media Contact:

Argot Partners

Leo Vartorella

[email protected]

KEYWORDS: United States North America California Delaware

INDUSTRY KEYWORDS: Biotechnology Professional Services Health Finance

MEDIA:

Posted on

B. Riley Financial Announces Pricing of $200 Million Offering of Senior Notes Due 2028

PR Newswire

LOS ANGELES, Jan. 20, 2021 /PRNewswire/ — B. Riley Financial, Inc. (NASDAQ: RILY) (“B. Riley” or the “Company”) today announced that on January 20, 2021 it priced an underwritten registered public offering of $200 million aggregate principal amount of 6.00% senior notes due 2028. The Company has granted the underwriters a 30-day option to purchase up to an additional $30 million aggregate principal amount of senior notes in connection with the offering. The offering is expected to close on January 25, 2021, subject to customary closing conditions.

B. Riley Financial and this issuance of notes both received an investment grade rating of BBB+ from Egan-Jones Ratings Company, an independent, unaffiliated rating agency. The Company has applied to list the notes on NASDAQ under the symbol “RILYT” and expects the notes to begin trading within 30 business days of the closing date of this offering, if approved.

The Company expects to use the net proceeds in excess of $50 million from the sale of the notes for the redemption of all or a portion of its existing 7.50% Senior Notes due 2027 as soon as practicable and the remaining net proceeds for general corporate purposes, including funding future acquisitions and investments, repaying indebtedness, making capital expenditures and funding working capital.

B. Riley Securities, Ladenburg Thalmann, National Securities Corporation, William Blair and Incapital are acting as book-running managers for this offering. Aegis Capital Corp., Boenning & Scattergood, Huntington Capital Markets, Kingswood Capital Markets, division of Benchmark Investments, Inc., Newbridge Securities Corporation and Wedbush Securities are acting as co-managers.

The notes will be offered under the Company’s shelf registration statement on Form S-3, which was declared effective by the Securities and Exchange Commission (“SEC”) on February 24, 2020. The offering of these notes will be made only by means of a prospectus supplement and accompanying base prospectus, which will be filed with the SEC.

Copies of the prospectus supplement and the accompanying base prospectus may be obtained on the SEC’s website at www.sec.gov, or by contacting B. Riley Securities by phone at (703) 312-9580, or by emailing [email protected].

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the notes in any state or jurisdiction in which such offer, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About B. Riley Financial (NASDAQ:RILY)
B. Riley Financial, Inc. provides collaborative financial services solutions tailored to fit the capital raising, business, operational, and financial advisory needs of its clients and partners. B. Riley operates through several subsidiaries which offer a diverse range of complementary end-to-end capabilities spanning investment banking and institutional brokerage, private wealth and investment management, corporate advisory, restructuring, due diligence, forensic accounting, litigation support, appraisal and valuation, and auction and liquidation services. Certain registered affiliates of B. Riley originate and underwrite senior secured loans for asset-rich companies. B. Riley also makes proprietary investments in companies and assets with attractive return profiles.

Forward-Looking Statements
Statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management’s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition and stock price could be materially negatively affected. You should not place undue reliance on such forward-looking statements, which are based on the information currently available to us and speak only as of the date of this press release. Such forward looking statements include, but are not limited to, statements regarding the terms and conditions and timing of the senior notes offering and the intended use of proceeds. Because these forward-looking statements involve known and unknown risks and uncertainties, there are important factors that could cause actual results, events or developments to differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ include (without limitation) the possibility that the notes offering will not be consummated at the expected time, on the expected terms, or at all; and the Company’s financial performance; and those risks described from time to time in B. Riley’s periodic filings with the SEC, including, without limitation, the risks described in B. Riley’s Annual Report on Form 10-K for the year ended December 31, 2019 under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Additional information is also set forth in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September 30, 2020. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. All information is current as of the date this press release is issued, and B. Riley undertakes no duty to update this information.


Contacts


Investors                 


Media

Investor Relations 

Jo Anne McCusker


[email protected]  


[email protected]

(310) 966-1444  

(646) 885-5425


 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/b-riley-financial-announces-pricing-of-200-million-offering-of-senior-notes-due-2028-301212087.html

SOURCE B. Riley Financial

Posted on

American Tower Corporation Announces Tax Reporting Information for 2020 Distributions

American Tower Corporation Announces Tax Reporting Information for 2020 Distributions

BOSTON–(BUSINESS WIRE)–
American Tower Corporation (NYSE: AMT)today announced year-end tax reporting information for its 2020 distributions. Stockholders are urged to consult with their personal tax advisors as to their specific tax treatment.

American Tower Corporation Common Stock

CUSIP 03027X100

Ticker Symbol: AMT

Record

Date

Payment

Date

Cash

Distribution

(per share)

Ordinary

Taxable

Dividends

(per share)

Qualified

Taxable

Dividends (1)

(per share)

 

Capital Gain

Distribution

(per share)

Section

199A

Dividends (1)

(per share)

04/14/2020

04/29/2020

$1.080000

$1.080000

$0.010354

$0.000000

$1.069646

06/19/2020

07/10/2020

$1.100000

$1.100000

$0.010546

$0.000000

$1.089454

09/28/2020

10/16/2020

$1.140000

$1.140000

$0.010929

$0.000000

$1.129071

(1) Included in Ordinary Taxable Dividends

Note: For the tax year ended December 31, 2020, there were no unrecaptured section 1250 gains or non-dividend distributions. Further, the quarterly distribution declared on December 3, 2020 and payable on February 2, 2021 will apply to the 2021 tax year.

This information represents final income allocations.

About American Tower

American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 183,000 communications sites. For more information about American Tower, please visit www.americantower.com.

Igor Khislavsky

Vice President, Investor Relations

Telephone: (617) 375-7500

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: REIT Finance Professional Services Commercial Building & Real Estate Construction & Property

MEDIA:

Logo
Logo
Posted on

Center Coast Brookfield MLP & Energy Infrastructure Fund to Redeem Outstanding Series a Mandatory Redeemable Preferred Shares and Announces Portfolio Management Team Update

NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) — Center Coast Brookfield MLP & Energy Infrastructure Fund (NYSE: CEN) (the “Fund”), a closed-end fund advised by Brookfield Public Securities Group LLC (“PSG”), today announced that on February 19, 2021 (the “Redemption Date”) it will redeem all of its outstanding Series A Mandatory Redeemable Preferred Shares (CUSIP No. 1514612#6), (“MRPS”).

The Fund also announced the expansion of the portfolio management team.

Redemption of Outstanding MRPS

On the Redemption Date, the Fund will redeem all 746 MRPS that remain outstanding, having an aggregate liquidation preference of $18,650,000. The redemption price per MRPS share will be the liquidation preference of $25,000, plus accumulated but unpaid dividends and distributions, up to, but excluding, the Redemption Date, plus a 1% redemption premium. Effective upon the redemption, the MRPS will no longer be deemed outstanding, dividends will cease to accumulate, and all the rights of the shareholders with respect to the MRPS will cease.   The Fund intends to utilize its existing revolving credit agreement to maintain its current leverage levels, subject to the limitations of the Investment Company Act of 1940 for borrowings by registered investment companies.

Portfolio Management Team Update

Messrs. Robert T. Chisholm and Jeff Jorgensen will be joined by Messrs. Boran Buturovic and Joe Herman as portfolio managers of the Fund. Each will share primary responsibility for overseeing the day-to-day management of the Fund.

The following provides information about each new portfolio manager’s business experience.

Boran Buturovic – Director, Portfolio Manager, Energy Infrastructure Securities

Boran Buturovic has 11 years of industry experience and is a Director on the Public Securities Group’s Energy Infrastructure Securities team. He is responsible for conducting MLP and energy infrastructure research and analysis. Prior to joining the firm in 2014, he was an Associate with UBS Investment Bank, focusing on midstream and MLPs. Boran started his career with Ernst & Young in their Assurance practice. Boran holds a CPA license in the state of Texas and he earned Bachelor of Business Administration and Master in Professional Accounting degrees from The University of Texas at Austin.  

Joe Herman – Director, Portfolio Manager, Energy Infrastructure Securities

Joe Herman has 10 years of industry experience and is a Director on the Public Securities Group’s Energy Infrastructure Securities team. He is responsible for conducting MLP and energy infrastructure research and analysis.   Prior to joining the firm in 2014, he was an Equity Research Associate with Tudor, Pickering, Holt & Co., focusing on midstream and MLPs. Prior to that, he was an Investment Banking Analyst at UBS Investment Bank.   Joe earned a Bachelor of Business Administration degree with majors in Business Honors and Finance and a Bachelor of Arts degree with majors in Plan II Honors and History from The University of Texas at Austin.  

About Brookfield Public Securities Group LLC

PSG is an SEC-registered investment adviser that represents the Public Securities platform of Brookfield Asset Management Inc., providing global listed real assets strategies including real estate equities, infrastructure equities, energy infrastructure equities, multi-strategy real asset solutions and real asset debt. With over $17 billion of assets under management as of December 31, 2020, PSG manages separate accounts, registered funds and opportunistic strategies for financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds and individual investors. PSG is a wholly owned subsidiary of Brookfield Asset Management Inc., a leading global alternative asset manager with approximately $575 billion of assets under management as of September 30, 2020. For more information, go to https://publicsecurities.brookfield.com/.
Center Coast Brookfield MLP & Energy Infrastructure Fund is managed by Brookfield Public Securities Group LLC. The Fund uses its website as a channel of distribution of material information about the Fund. Financial and other material information regarding the Fund is routinely posted on and accessible at https://publicsecurities.brookfield.com/.

Forward-Looking Statements

Certain statements made in this news release that are not historical facts are referred to as “forward-looking statements” under the U.S. federal securities laws. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements due to numerous factors. Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ from the historical experience of PSG, and the Fund managed by PSG, and its present expectations or projections. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. PSG and the Fund managed by PSG undertake no responsibility to update publicly or revise any forward-looking statements.


COMPANY CONTACT


Center Coast Brookfield MLP & Energy Infrastructure Fund

Brookfield Place
250 Vesey Street, 15th Floor
New York, NY 10281-1023
(855) 777-8001
[email protected]

Investing involves risk; principal loss is possible. Past performance is not a guarantee of future results.

Risks

The outbreak of an infectious respiratory illness caused by a novel coronavirus known as “COVID-19” is causing materially reduced consumer demand and economic output, disrupting supply chains, resulting in market closures, travel restrictions and quarantines, and adversely impacting local and global economies. As with other serious economic disruptions, governmental authorities and regulators are responding to this crisis with significant fiscal and monetary policy changes, including by providing direct capital infusions into companies, introducing new monetary programs and considerably lowering interest rates, which in some cases resulted in negative interest rates. These actions, including their possible unexpected or sudden reversal or potential ineffectiveness, could further increase volatility in securities and other financial markets, reduce market liquidity, heighten investor uncertainty and adversely affect the value of the Fund’s investments and the performance of the Fund. Markets generally and the energy sector specifically, including master limited partnerships (“MLPs”) and energy infrastructure companies in which the Fund invests, have also been adversely impacted by reduced demand for oil and other energy commodities as a result of the slowdown in economic activity resulting from the spread of COVID-19 and by price competition among key oil-producing countries. These developments have and may continue to adversely impact the Fund’s NAV and the market price of the Fund’s common shares.

The Fund’s investments are concentrated in the energy infrastructure industry with an emphasis on securities issued by MLPs, which may increase price fluctuation. The value of commodity-linked investments such as the MLPs and energy infrastructure companies (including midstream MLPs and energy infrastructure companies) in which the Fund invests are subject to risks specific to the industry they serve, such as fluctuations in commodity prices, reduced volumes of available natural gas or other energy commodities, slowdowns in new construction and acquisitions, a sustained reduced demand for crude oil, natural gas and refined petroleum products, depletion of the natural gas reserves or other commodities, changes in the macroeconomic or regulatory environment, environmental hazards, rising interest rates and threats of attack by terrorists on energy assets, each of which could affect the Fund’s profitability.

MLPs are subject to significant regulation and may be adversely affected by changes in the regulatory environment including the risk that an MLP could lose its tax status as a partnership. If an MLP was obligated to pay federal income tax on its income at the corporate tax rate, the amount of cash available for distribution would be reduced and such distributions received by the Fund would be taxed under federal income tax laws applicable to corporate dividends received (as dividend income, return of capital, or capital gain).

In addition, investing in MLPs involves additional risks as compared to the risks of investing in common stock, including risks related to cash flow, dilution and voting rights. Such companies may trade less frequently than larger companies due to their smaller capitalizations which may result in erratic price movement or difficulty in buying or selling.

The Fund is a non-diversified, closed-end management investment company. As a result, the Fund’s returns may fluctuate to a greater extent than those of a diversified investment company. Shares of closed-end management investment companies, such as the Fund, frequently trade at a discount to their net asset value, which may increase investors’ risk of loss. The Fund is not a complete investment program and you may lose money investing in the Fund.

Because of the Fund’s concentration in MLP investments, the Fund is not eligible to be treated as a “regulated investment company” under the Internal Revenue Code of 1986, as amended. Instead, the Fund will be treated as a regular corporation, or “C” corporation, for U.S. federal income tax purposes and, as a result, unlike most investment companies, will be subject to corporate income tax to the extent the Fund recognizes taxable income.

An investment in MLP units involves risks that differ from a similar investment in equity securities, such as common stock, of a corporation. Holders of MLP units have the rights typically afforded to limited partners in a limited partnership. As compared to common shareholders of a corporation, holders of MLP units have more limited control and limited rights to vote on matters affecting the partnership. There are certain tax risks associated with an investment in MLP units. Additionally, conflicts of interest may exist between common unit holders, subordinated unit holders and the general partner of an MLP.

The Fund currently seeks to enhance the level of its current distributions by utilizing financial leverage through borrowing, including loans from financial institutions, or the issuance of commercial paper or other forms of debt, through the issuance of senior securities such as preferred shares, through reverse repurchase agreements, dollar rolls or similar transactions or through a combination of the foregoing. Financial leverage is a speculative technique and investors should note that there are special risks and costs associated with financial leverage.

Foreside Fund Services, LLC; distributor.



Posted on

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Oxford Immunotec Global PLC Buyout

WILMINGTON, Del., Jan. 20, 2021 (GLOBE NEWSWIRE) — Rigrodsky Law, P.A. announces that it is investigating Oxford Immunotec Global PLC (“Oxford Immunotec”) (NASDAQ GS: OXFD) regarding possible breaches of fiduciary duties and other violations of law related to Oxford Immunotec’s agreement to be acquired by PerkinElmer, Inc. (“PerkinElmer”) (NYSE: PKI). Under the terms of the agreement, Oxford Immunotec’s shareholders will receive $22.00 in cash per share.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-oxford-immunotec-global-plc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky Law, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
[email protected]
https://rl-legal.com



Posted on

KNDI SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Kandi Technologies Group, Inc.

NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Kandi Technologies Group, Inc. (“Kandi” or the “Company”) (NASDAQ: KNDI) from March 15, 2019 through November 27, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Eastern District of New York alleges violations of the Securities Exchange Act of 1934.

If you purchased Kandi securities, and/or would like to discuss your legal rights and options please visit Kandi Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (2) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (3) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.

On November 30, 2020, Hindenburg Research (“Hindenburg”) published a report entitled: “Kandi: How This China-Based NASDAQ-Listed Company Used Fake Sales, EV Hype to Nab $160 Million From U.S. Investors.” Citing “extensive on-the-ground inspection at Kandi’s factories and customer locations in China, interviews with over a dozen former employees and business partners, and review of numerous litigation documents and international public records,” the Hindenburg report asserted that almost 64% of Kandi’s sales over the year have been to undisclosed related parties. The report also alleged that “[Kandi] has consistently booked revenue it cannot collect, a classic hallmark of fake revenue[.]”

Following publication of the Hindenburg report, Kandi’s stock price fell $3.86 per share, or 28.34%, to close at $9.76 per share on November 30, 2020.

If you wish to serve as lead plaintiff, you must move the Court no later than February 9, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Kandi securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/kanditechnologiesgroupinc-kndi-shareholder-class-action-lawsuit-stock-fraud-337/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]